Nat Cell Biol. 2018 Jun;20(6):710-720. doi: 10.1038/s41556-018-0104-5. Epub 2018 May 25.

Single-cell analysis identifies a CD33⁺ subset of human cord blood cells with high regenerative potential.

Knapp DJHF^1,2, Hammond CA^1,2, Hui T³, van Loenhout MTJ³, Wang F^1,4, Aghaeepour N⁵, Miller PH^1,2, Moksa M³, Rabu GM¹, Beer PA¹, Pellacani D¹, Humphries RK^1,2, Hansen C^3,6, Hirst M^3,7, Eaves CJ^8,9,10.

Abstract

Elucidation of the identity and diversity of mechanisms that sustain long-term human blood cell production remains an important challenge. Previous studies indicate that, in adult mice, this property is vested in cells identified uniquely by their ability to clonally regenerate detectable, albeit highly variable levels and types, of mature blood cells in serially transplanted recipients. From a multi-parameter analysis of the molecular features of very primitive human cord blood cells that display long-term cell outputs in vitro and in immunodeficient mice, we identified a prospectively separable CD33⁺CD34⁺CD38^-CD45RA^-CD90⁺CD49f⁺ phenotype with serially transplantable, but diverse, cell output profiles. Single-cell measurements of the mitogenic response, and the transcriptional, DNA methylation and 40-protein content of this and closely related phenotypes revealed subtle but consistent differences both within and between each subset. These results suggest that multiple regulatory mechanisms combine to maintain different cell output activities of human blood cell precursors with high regenerative potential.